B.Riley Reiterates Buy Rating on Journey Medical Corp. (DERM) Feb 4, 2026 06:49AM
Journey Medical Corp (DERM) files $150M mixed shelf Jan 15, 2026 04:45PM
Dermira (DERM) Misses Q3 EPS by 6c Nov 12, 2025 06:17PM
H.C. Wainwright Starts Journey Medical Corp. (DERM) at Buy Aug 25, 2025 06:34AM
Dermira (DERM) Misses Q2 EPS by 5c Aug 12, 2025 04:02PM


Jul 14, 2025 08:31AM Journey Medical expands Emrosi payer coverage to 65% of commercial lives
Jun 24, 2025 08:31AM Journey Medical Corp (DERM) set to join Russell 2000 and 3000
Jun 20, 2025 08:32AM Journey Medical Corp (DERM) Announces Emrosi Data Analysis to be Presented at SDPA
May 14, 2025 04:19PM Dermira (DERM) Misses Q1 EPS by 8c
Apr 1, 2025 04:01PM Journey Medical Corp (DERM) Appoints Ramsey Alloush as COO
Mar 5, 2025 04:01PM Journey Medical Corp (DERM) Announces Publication of the Phase 3 Clinical Trial Results of Emrosi
Nov 12, 2024 04:04PM Dermira (DERM) Tops Q3 EPS by 5c
Nov 4, 2024 07:01AM Journey Medical Corp (DERM) Announces U.S. FDA Approval of Emrosi
Oct 17, 2024 04:18PM SWK Holdings (SWKH) Provides Portfolio Update
Oct 17, 2024 04:15PM SWK Holdings Provides Portfolio Update
Sep 6, 2024 08:44AM Lake Street Capital Markets Starts Journey Medical Corp. (DERM) at Buy
Aug 13, 2024 06:55AM B.Riley Reiterates Buy Rating on Journey Medical Corp. (DERM)
Aug 12, 2024 04:05PM Dermira (DERM) Misses Q2 EPS by 3c, reaffirms FY Guidance
Jul 17, 2024 04:15PM SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
Jul 11, 2024 04:06PM Journey Medical Corp (DERM) Appoints Michael C. Pearce to its Board
Jun 28, 2024 04:54AM Roth/MKM Assumes Journey Medical Corp. (DERM) at Buy